Effect of transforming growth factor-β1, fibronectin and plasminogen activator inhibitor on migration of bovine aortic endothelial cells
|
|
- Jasper Clarke
- 5 years ago
- Views:
Transcription
1 Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1996 Effect of transforming growth factor-β1, fibronectin and plasminogen activator inhibitor on migration of bovine aortic endothelial cells Christine E. Brozowski Yale University Follow this and additional works at: Recommended Citation Brozowski, Christine E., "Effect of transforming growth factor-β1, fibronectin and plasminogen activator inhibitor on migration of bovine aortic endothelial cells" (1996). Yale Medicine Thesis Digital Library This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar A Digital Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
2 YALE MEDICAL LIBRARY EFFECT-OS : fibrone GROWTH FACT ACTIVA PLASM inogli OVINE.AORTIC' ENDOTHEUAi CHRISTINE
3 YALE UNIVERSITY CUSHING/WHITNEY MEDICAL LIBRARY
4 Digitized by the Internet Archive in 2017 with funding from The National Endowment for the Humanities and the Arcadia Fund
5
6
7
8
9
10 Effect of Transforming Growth Factor-pl, Fibronectin and Plasminogen Activator Inhibitor on Migration of Bovine Aortic Endothelial Cells. A Thesis Submitted to the Yale University School of Medicine in Partial Fulfillment of the Requirements for the Degree of Doctor in Medicine by Christine E. Brozowski May 1996
11 VALE MEDICAL LIBRARY AUG HEP "T113 + YIZ bis 7
12 Abstract EFFECT OF TRANSFORMING PLASMINOGEN ACTIVATOR ENDOTHELIAL A. CELLS. Madri). of Medicine, Restenosis and procedures lead to of New Haven, CT. the Pathology, largest and formation proliferation, of have influence The of this transforming growth factor University, School of endarterectomy trauma of a have cells investigation (TGF-(3l), and was the Later of studies 50ug/ml which was in using a significantly our resulted a student's decrease laboratory in to effect (Fn), of and TGF- (31 decreased migration by 28% significant not shown on migration of bovine were did the endothelial fibronectin (PAI-2) cell and been Fibronectin decreased migration by 19% +. 4%. loug/ml by neointima. muscle 3%. (p<0.05) caused synthesis, factors muscle plasminogen activator inhibitor aortic endothelial cells. Joseph smooth matrix Growth smooth target on and on by Vascular development depends endothelium. BOVINE AORTIC (Sponsored Yale AND in deundation injury which may the migration, presence FIBRONECTIN complication angioplasty. hyperplasia an Brozowski such as these result Neointimal cells. Christine catheter FACTOR-(3l, INHIBITOR ON MIGRATION OF Department remains balloon GROWTH using decreased statistically significant. Both values t-test. migration higher migration (6% levels of + 10% PAI-2 at ± 4%). of + PAI-2 3%, TGF-(3l has been shown to
13
14 be present in injury in vivo. migration and migration. vascular significant increases the rate is mediated this by sites of increases the likelihood smooth suggests that modulation of the of effects of vascular endothelial the presence of TGF-(3l at fibronectin can partially mimic migration, at TGF- (31 decreases the rate of Therefore, lesion quantities muscle the TGF-pl the TGF- Pi effect the extracellular on cell site of a restenosis. of cell on Since BAEC migration matrix. The effect of TGF- Pi on endothelial cell migration may also be due to increased expression of PAI-2 PAI or decreased upa expression, decreases BAEC migration. as
15
16
17
18 2 Introduction Balloon angioplasty, endarterectomy, and synthetic grafting are therapeutic interventions currently performed to alleviate the effects of atherosclerosis. It has been estimated that over 350,000 coronary angioplasty procedures were performed in the United States in Restenosis remains the most important limitation of angioplasty, with studies suggesting that up to 50% of patients will develop restenoses within one year, with up to 20% of patients necessitating a repeat operation within 6 months.2,3 Procedures such as angioplasty result in endothelial denudation injury to the blood vessel wall Stenosing intimal lesions may develop from intimal hyperplasia which narrows the vessel lumen, and can compromise blood flow. This ultimately results in a failure of the reconstruction.4 The formation of a neointima after vascular injury depends on smooth muscle cell proliferation and migration and the synthesis of a new extracellular matrix.4 The normal tunica intima is composed of endothelial cells and smooth muscle cells.5 Endothelial cells line the vascular system, forming a nonthrombogenic surface for blood flow and covering smooth muscle cells. Smooth muscle cells compose the media of large vessels, maintain vessel wall integrity, control vascular tone and influence endothelial cell behavior. Following denudation injury, medial smooth muscle cells proliferate and migrate rapidly into the intima where they synthesize components which may narrow the vessel lumen. Endothelial cells migrate more slowly from the edges of the wound to reconstitute the damaged endothelial cell layer and reestablish vessel wall integrity, critical to maintaining lumen patency.6 Stimuli
19
20 3 which retard migration of endothelial cells and enhance the migration of smooth muscle cells lead to the development of stenotic lesions at the site of vascular injury.7 Transforming growth factor (TGF-(3l), a component of platelet a granules, is synthesized and secreted by endothelial and smooth muscle cells.7 TGF-[3l regulates critical cell functions including growth, differentiation, activation, and migration.8 Specifically, TGF-(3l has been shown to be present in significant quantities at sites of vascular injury in vivo, and markedly inhibits endothelial cell migration and vessel wall repair following injury.9 It has been suggested that the TGF-(3l mediated decrease in endothelial cell migration is associated with increased expression of fibronectin (Fn) and plasminogen activator inhibitor (PAI-2)8. This report documents the effect of transforming growth factor (TGF-(31), fibronectin (Fn), and plasminogen activator inhibitor (PAI-2) on migration of bovine aortic endothelial cells as an in vitro model of re-endothelialization and repair of denudation injury such as that produced by balloon catheter angioplasty. Methods Bovine aortic endothelial cells (BAEC) were isolated and cultured with DMEM and 10% fetal calf serum (FCS). The cells were seeded into the middle of a steel fence with a known area and allowed to attach to the underlying type I collagen matrix below, and grow to confluency for 4-5 hours. The fence was then removed. With the loss of contact inhibition, cell migration radially outward was initiated. The cells were covered in media alone or with media plus
21
22 4 exogenous transforming growth factor (TGF-[3l) at a final concentration of 0.5 ng/ml, plasminogen activator inhibitor (PAI-2) at a final concentration of 10 ug/ml, fibronectin (Fn) at a final concentration of 50 ug/ml, Aprotinin at 50 ug/ml, or EACA at 50 ug/ml. The cells migrated radially outward for six days, and were fed with additional media plus the appropriate growth factors at day three. Migrations were stopped 6 days post initiation of treatment. The cultures were then washed in PBS and fixed with 10% Buffered Formalin. Cells were stained with Harris' hematoxylin to evaluate cell migration. Petri dishes with stained cells were placed on an overhead projector to assess surface area covered by the cells. The surface areas were transferred to paper and a computer graphics tablet was used to quantify surface areas obtained by overhead projection. These surface areas were compared with known values of the initial fence area to obtain the net increase in surface area. Maximal response was obtained using DMEM media and 10% FCS only, thus, this was defined as the control with 100% relative migration. Migration in the presence of growth factors (TGF-(3l, Fn, PAI-2, EACA and Aprotinin) was compared and normalized to this value. Bar graphs were generated from mean values. The differences in means were analyzed using a student's t-test. Statistical significance was assumed for P<0.05. Results Treatment with TGF-pl decreased the distance of migration of BAEC on a type 1 collagen matrix by 28% + 3% compared to control. Fibronectin showed a 19% + 4% inhibition of
23
24 5 migration distance. These were significant (p<0.05) using a student's t-test. In contrast, treatments with EACA, Aprotinin and EACA & Aprotinin did not show a significant decrease in migration compared to the control group. EACA and Aprotinin are non-specific protease inhibitors. These results suggest that non-specific protease inhibitors do not decrease the migration of endothelial cells. See Figure 1. PAI-2 at loug/ml showed only a 6% ± 4% decrease in migration which was not statistically significant. In later BAEC migration studies in our laboratory, however, PAI-2 concentration was increased to 50ug/ml with a significant decrease in migration of 10% + 3%. In additional studies, Petzelbauer et al demonstrated that stable over-expression of PAI-1 protein in BAEC using retroviral transduction resulted in a significant inhibition of BAEC migration. The g resultant BAEC migration was found to decrease 23% ± 2%. Discussion Repair of arterial injury produced by balloon angioplasty or atherectomy leads to the development of an intimal thickening and a subsequent narrowing of the vessel lumen.10 Neointimal formation depends on smooth muscle cell proliferation, migration, and matrix synthesis, and the presence/absence of an endothelium4 The two major cell types of the vessel wall, the smooth muscle cell and the endothelial cell, respond differently to injury. Medial SMCs begin to migrate from the media into the intima. Many cells proliferate, but up to one half do not divide 4 Once in the intima, SMCs continue to proliferate and form a thick layer.
25
26 % Inhibition of Migration 40 -i n=6 10 n=8 - T 0 IF -10 o 1 c o O 1 CC LL o c LL CVJ < CL < o < LU c 'c o Q_ < _c 'c Q. < + < O < LU Treatment Figure 1
27
28 6 The resulting neointima is further enlarged by extracellular matrix components synthesized by the smooth muscle cells. Endothelial cells, on the other hand, migrate more slowly from around the area of denudation to reconstitute the damaged endothelial cell layer. The cells at the edge of the wound divide and migrate inward, but the central portion of large injuries may remain uncovered.4'11 Importantly, proliferation of intimal smooth muscle cells ceases earlier in areas covered by regenerating endothelium than in regions lacking an endothelium.4 Primary lesions differ from restenotic lesions in that primary lesions consist of well-organized collagen and ground substance, and are hypocellular, while restenotic lesions have foci of hypercellularity consisting of proliferative vascular smooth muscle cells with associated matrix proteins.12 These smooth muscle cells have an unusual elongated shape with processes extending from the cells and are accompanied by significant matrix deposition composing 5060% of lesion size between the cells.12 Advanced atherosclerotic lesions show progressive development of small denuded regions. This loss of continuity of the endothelium in the evolution of atherosclerosis suggests that some property of the atheromatous wall or blood interacting with the wall is responsible for the inhibition of endothelial regeneration.1' Both platelet deposition and growth factor release have been suggested as important events initiating the cellular growth response after injury.12,14 A variety of growth factors have been described in vascular smooth muscle cells and/or atherosclerotic tissue, and have, therefore, been inferred to play a role in the development of restenosis lesions. These include the transforming growth factor-(3s, platelet-derived growth factors and receptors, fibroblast growth
29
30 7 factors, and insulin-like growth factors.15 Platelet-derived growth factor (PDGF) has been found to exert little effect on smooth muscle cell replication, but markedly influences the ability of SMCs to migrate into the intima.16 TGF-(3l is a major component of platelet releasates and is synthesized and secreted by endothelial cells and smooth muscle cells.7 TGF-(3l has been shown to inhibit proliferation of endothelial cells, and to retard epithelial wound healing in vitro.17 TGF-(3l influences matrix production and protease inhibitors, both of which affect migration of endothelial cells. Additionally, TGF-(3l has been demonstrated to stimulate the proliferation of smooth muscle cells and the production of elastin and proteoglycan, common features of atherosclerotic plaques.15 TGF-(3l has been shown to be present in significant quantities at sites of vascular injury in vivo.8,10,18 In addition to decreasing endothelial cell migration, TGF-(3l has been documented to increase vascular smooth muscle cell migration.19 Stimuli which enhance migration of medial smooth muscle cells into the intima where they can synthesize matrix components leading to the development of a stenotic lesion at the site of vascular injury may result in the eventual occlusion of the vessel lumen.6 Because TGF-(3l decreases the rate of endothelial cell migration and increases the rate of smooth muscle cell migration, the presence of TGF-(3l at the site of a vascular lesion increases the likelihood of restenosis. Additional steps involved in restenosis include the release of growth factors, proteoglycan deposition and release of growth factors, proteoglycan deposition and extracellular matrix remodeling.2,20 Potential inhibitors at each step could be used as preventative therapy.
31
32 TGF-(3l influences matrix production and protease inhibitors, both of which affect migration of endothelial cells. TGF-(3l has been observed to down-regulate the expression of upa activity in endothelial cells.21 Endothelial cells express tissue-type plasminogen activator (tpa), urokinase-like plasminogen activator (upa) and plasminogen activator inhibitor (PA1). upa interaction with the upa receptor has been associated with an increase in endothelial cell motility.8 PAI-2 is a protease inhibitor which is specific for upa receptor sites, and decreases BAEC migration. TGF-(3l decreases the expression of upa and subsequently lessens the rate of migration of endothelial cells. Thus, the TGF-(5l effect on BAEC migration may be due to the combined effects of increased expression of PA1, decreased upa expression, and influencing the extracellular matrix (increased fibronectin deposition). In other studies in our laboratory, Petzelbauer et al showed that unlike endothelial cells, bovine aortic smooth muscle cells exhibited an increased rate of migration in response to the addition of exogenous TGF-(3l, fibronectin or PAI-2, or by the stable over-expression of PAI-1 protein. Endothelial cell replication and migration are triggered by damage to the vessel wall These cells migrate from the leading edge of a lesion to reestablish the endothelial monolayer, and repair the vessel wall It has been shown that TGF-(3 inhibits both endothelial replication and migration, thus decreasing endothelial regeneration.13 Heimark,13 et al demonstrated that TGF-(3 transiently decreases DNA synthesis in endothelial cells. Specifically, TGF-(3 delays the entry of regenerating endothelial cells into the S phase. Once cells have passed into S or G2, however, they are no longer responsive to TGF-(3.
33
34 9 Increased TGF- 3l gene expression has been found in rat carotid arteries after balloon catheter injury.8,10 In studies by Nikol,15 et al, human atherosclerotic tissue specimens were examined for TGF-(3l mrna. Primary atherosclerotic lesions showed slightly, but not significantly, higher TGF-(3l expression than non-atherosclerotic tissue. TGF-(3l was maximally expressed in restenotic tissues. TGF-(3l expression in restenotic atherosclerotic tissues was significantly greater than that found in primary atherosclerotic tissue, consistent with the hypothesis that increased TGF-(3l mrna expression is related to smooth muscle cell proliferation.15 These results suggest a role for TGF-(3l in the development of restenosis lesions. Neointimal formation requires the synthesis of a new extracellular matrix. Major constituents of matrices produced by intimal SMCs include fibronectin, elastin and type I collagen.10 The addition of exogenous TGF-(3l to arterial SMC in vitro has been shown to stimulate extracellular protein synthesis.10 TGF-(3l has been shown to increase fibronectin production in endothelial cells, smooth muscle cells and fibroblasts.8,22 Fibronectin promotes rapid attachment of bovine aortic endothelial cells, but little migration.21 BAECs treated with TGF(31 have shown increased fibronectin mrna levels, and synthesis and deposition of fibronectin8,19. Increased mrna levels of fibronectin and collagen a2(i) have been found to correlate with the onset of neointimal formation.10 In this paper we have shown that the addition of exogenous TGF-(3l or fibronectin decreases BAEC migration. Fibronectin can partially mimic the effects of TGF-(3l on BAEC migration
35
36 10 suggesting that the TGF-(3l effect on migration is mediated by modulation of the synthetic matrix. TGF-(3l alters matrix production by increasing fibronectin deposition, increasing PAI expression, and decreasing upa expression.8 The majority of medical therapies designed to prevent restenosis are aimed at reducing smooth muscle cell migration as the primary cause of restenoses pathology. However, enhancement of endothelial cell regeneration and decreased matrix production are other potential targets to consider as proliferation of smooth muscle cells ceases earlier in areas covered by an regenerating endothelium, and as the matrix composes a large part of the lesion volume. Conclusion This paper has demonstrated that TGF-(3l and fibronectin inhibit migration of bovine aortic endothelial cells. Other studies in our laboratory have shown that the addition of exogenous PAI-2 in high concentration (50ug/ml) also decreased BAEC migration, and that PAI & TGF(31, and Fn & TGF-(3l were not additive. Therefore, we surmise that TGF-(3l alters matrix production by increasing fibronectin deposition, increasing PAI-2 expression and decreasing upa expression. Conversely, TGF-(3l has been shown to enhance migration in smooth muscle cells. Previous studies have shown that the most intimal smooth muscle cell proliferation occurs in the region last covered by regenerating endothelium.24,25 Therefore, stimuli which retard the migration of endothelial cells and enhance the migration of smooth muscle cells lead to the development of stenotic lesions at the site of vascular injury. Consequently, reducing the
37
38 11 TGF-pl burden at the site of vascular lesion may decrease the incidence of restenosis following vascular injury.
39
40 12 References 1. Faxon, D.P., and J.W. Currier, Prevention of post-ptca Restenosis. Annals of the New York Academy of Sciences, 748:419-27, Nobuyoshi, M., Kimura, T., Noksaka, H., Mioka, S., Veno, K., Yokoi, H., Hamasaki, N., Horiuchi, H., and H. Ohishi, Restenosis After Successful Percutaneus Transluminal Coronary Angioplasty: Serial Angiographic Follow-up of 229 Patients. Journal of the American College of Cardiology, 12(3):616-23, Serruys, P.W., Luijten, H.E., Beatt, K.J., Geuskens, R., de Feyter, P.J., van den Brand, M., Reiber, J.H., ten Katen, H.J., van Es, G.A., and P.G. Hugenholtz, Incidence of Restenosis After Successful Coronary Angioplasty: A Time-Related Phenomenon. A Quantitative Angiographic Study in 342 Consecutive Patients at 1, 2, 3, and 4 Months. Circulation, 77(2): , Clowes, A.W., and M.A. Reidy, Prevention of Stenosis After Vascular Reconstruction: Pharmacologic Control of Intimal Hyperplasia - A Review. Journal of Vascular Surgery, 13(6):885-91, Bondjers G., Glukhora M., Hansson G.K., Postnov, Y.V., Reidy M.A., and S.M. Schwartz, Hypertension and Atherosclerosis. Cause and Effect, or Two Effects with One Unknown Cause? Circulation, 84(6Suppl):V12-16, Bell, L., Luthringer, D.J., Madri, J.A., and S.L. Warren, Autocrine Angiotensin System Regulation of Bovine Aortic Endothelial Cell Migration and Plasminogen Activator Involves Modulation of Proto-oncogene pp60c-src Expression. Journal of Clinical Investigation, 89: , Madri, J.A., and L. Bell, Vascular Cell Responses to Injury: Modulation by Extracellular Matrix and Soluble Factors. Cell Interactions in Atherosclerosis, ed. H. Robenek and N.J. Severs Petzelbauer, E., Springhom, J.P., Tucker, A.M., and J.A. Madri, The Role of Plasminogen Activator Inhibitor in the Reciprocal Regulation of Bovine Aortic Endothelial and Smooth Muscle Cell Migration by TGF-(3l. American Journal of Pathology In Revision Madri, J.A., Reidy, M.A., Kocher, O., and L. Bell, Endothelial Cell Behavior After Denudation Injury Is Modulated by Transforming Growth Factor-(3l and Fibronectin. Laboratory Investigation, 60 (6): , Majesky, M.W., Lindner, V., Twardzik, D.R., Schwartz, S.M., and M.A. Reidy, Production of Transforming Growth Factor (Jl during Repair of Arterial Injury. Clinical Investigation, 88: , Journal of
41
42 Reidy, M.A., Clowes, A.W., and S.M. Schwartz, Endothelial Regeneration: V. Inhibition of Endothelial Regrowth in Arteries of Rat and Rabbit. Laboratory Investigation, 49(5): , Isner, J.M., Vascular Remodeling: Honey, I Think I Shrunk the Artery. Circulation, 89(6): , Heimark, R.L., Twardzik, D.R., and S.M. Schwartz, Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets. Science, 233, , Wilcox, J.N., Molecular Biology: Insight into the Causes and Prevention of Restenosis After Arterial Intervention. American Journal of Cardiology, 72:88E-95E, Nikol, S., Isner, J.M., Pickering, G., Kearney, M., Leclerc, G., and L. Weir, Expression of Transforming Growth Factor-(3l Is Increased in Human Vascular Restenosis Lesions. Journal of Clinical Investigation, 10: , Reidy, M.A., Fingerle, J., and V. Lindner, Factors Controlling the Development of Arterial Lesions After Injury. Circulation, 86 (SuppL III): 43-III-46, Biro, S., Yu, Z.X., and W. Casscells. Fibroblast and Transforming Growth Factors in Endothelial Wound Healing in vitro. Journal of the American College of Cardiology, 17:24A (Abstr.), Reidy, M.A., Factors Controlling Smooth-Muscle Cell Proliferation. Archives of Pathology & Laboratory Medicine, 116(12): , Madri, J.A., Bell, L., and J.R. Merwin, Modulation of Vascular Cell Behavior by Transforming Growth Factors (3. Molecular Reproduction and Development, 32: , Forrester, J.S., Fishbein, M., Helfant, R., and J. Fagin, A Paradigm for Restenosis Based on Cell Biology: Clues for the Development of New Preventive Therapies. Journal of the American College of Cardiology, 17: , Sankar, S., Mahooti-Brooks, N., Centrella, M., McCarthy, T.L., and J.A. Madri, Expression of Transforming Growth Factor Beta Type HI Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor (32. Biological Chemistry, 270(22): , Journal of
43
44 Madri. J.A., Pratt, B.M., and J. Yannariello-Brown, Matrix-Driven Cell Size Change Modulates Aortic Endothelial Cell Proliferation and Sheet Migration. American Journal of Pathology, 132(1): 18-27, Pratt, B.M., Form, D., and J.A. Madri, Endothelial Cell-Extracellular Interactions. Annals of the New York Academy of Sciences, 460: , Matrix 24. Clowes, A.W., Reidy, M.A., and M.A. Clowes, Kinetics of Cellular Proliferation after Arterial Injury: I. Smooth Muscle Growth in the Absence of Endothelium. Laboratory Investigation, 49(3): , Fishman, J.A., Ryan, G.B., and M.J. Kamovsky, Endothelial Regeneration in the Rat Carotid Artery and the Significance of Endothelial Denudation in the Pathogenesis of Myointimal Thickening, Laboratory Investigation 32: , 1975.
45
46
47
48 HARVEY CUSHING / JOHN HAY WHITNEY MEDICAL LIBRARY MANUSCRIPT THESES Unpublished theses submitted for the Master's and Doctor's degrees and deposited in the Medical Library are to be used only with due regard to the rights of the authors. Bibliographical references may be noted, but passages must not be copied without permission of the authors, and without proper credi being given in subsequent written or published work. This thesis by has been used by the following persons, whose signatures attest their acceptance of the above restrictions. NAME AND ADDRESS DATE
49
Invited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases
Histol Histopathol (2000) 15: 557-571 Histology and Histopathology Cellular and Molecular Biology Invited Review Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationBiology of in-stent restenosis and rational for debulking
LINC 2016 Leipzig January 26-29 2016 Biology of in-stent restenosis and rational for debulking Jos C. van den Berg, MD PhD Ospedale Regionale di Lugano, sede Civico Lugano Switzerland ISR-complexity Osherov
More informationATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber
ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.
More informationRADIOBIOLOGICAL PRINCIPLES IN INTRAVASCULAR IRRADIATION
Cardiovascular Radiation Medicine 1:1 (1999) 42 47 BIOLOGY/PATHOLOGY ORIGINAL ARTICLE RADIOBIOLOGICAL PRINCIPLES IN INTRAVASCULAR IRRADIATION Eric J. Hall, D.Sc.,* Richard C. Miller, Ph.D., and David J.
More informationThe Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice
The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr
More informationPathology of Cardiovascular Interventions. Body and Disease 2011
Pathology of Cardiovascular Interventions Body and Disease 2011 Coronary Artery Atherosclerosis Intervention Goals: Acute Coronary Syndromes: Treat plaque rupture and thrombosis Significant Disease: Prevent
More informationIII. Results and Discussion
III. Results and Discussion 1. Histological findings in the coronary artery Twenty-four swine had surgical treatments performed in two of the coronary arteries, LAD as well as either the LCX or RCA. A
More informationThe effect of cholesterol-related knowledge on patients' ability to reach target cholesterol levels
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 2003 The effect of cholesterol-related knowledge on patients' ability
More informationAbstract. S.L.D. Dalle Lucca 1, J.J. Dalle Lucca 1, A.C.R. Borges 1, S.S.M. Ihara 2 and T.B. Paiva 1
Brazilian Journal of Medical and Biological Research (2000) 33: 919-927 Abnormal proliferative response of the SHR ISSN 0100-879X 919 Abnormal proliferative response of the carotid artery of spontaneously
More informationSmooth muscle pharmacology & interventional cardiology
Smooth muscle pharmacology & interventional cardiology By: Pascal Bernatchez!!!!! LAST LECTURE Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure
More informationCatheter and stent-based brachytherapy have shown promise
Late Arterial Responses (6 and 12 Months) After 32 -Emitting Stent lacement Sustained Intimal Suppression With Incomplete Healing Andrew Farb, MD; Sweta Shroff, MS; Michael John, BA; William Sweet, MD;
More informationRestenosis after coronary angioplasty occurs in 20% to
Bolus Endovascular PDGFR- Antisense Treatment Suppressed Intimal Hyperplasia in a Rat Carotid Injury Model Nicolas Noiseux, MD, MSc; Caroline H. Boucher, BSc; Raymond Cartier, MD; Martin G. Sirois, PhD
More informationIntracoronary Serum Smooth Muscle Myosin Heavy Chain Levels Following PTCA may Predict Restenosis
Clinical Studies Intracoronary Serum Smooth Muscle Myosin Heavy Chain Levels Following PTCA may Predict Restenosis Yasuhiro TSUCHIO,MD,ShigetoNAITO, MD, Akihiko NOGAMI,MD, Hiroshi HOSHIZAKI, MD, ShigeruOSHIMA,
More informationTissue repair. (3&4 of 4)
Tissue repair (3&4 of 4) What will we discuss today: Regeneration in tissue repair Scar formation Cutaneous wound healing Pathologic aspects of repair Regeneration in tissue repair Labile tissues rapid
More informationTissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science
Tissue renewal and Repair Nisamanee Charoenchon, PhD Email: nisamanee.cha@mahidol.ac.th Department of Pathobiology, Faculty of Science Topic Objectives 1. Describe processes of tissue repair, regeneration
More informationMichael T. Caps, MD, Thomas S. Hatsukami, MD, Jean F. Primozich, BS, RVT, Robert O. Bergelin, MS, and D. Eugene Strandness, Jr., MD, Seattle, Wash.
A clinical marker for arterial wall The double line healing: Michael T. Caps, MD, Thomas S. Hatsukami, MD, Jean F. Primozich, BS, RVT, Robert O. Bergelin, MS, and D. Eugene Strandness, Jr., MD, Seattle,
More informationIn-stent Restenosis: the Achille's Heel of SFA Stenting
In-stent Restenosis: the Achille's Heel of SFA Stenting Yann Gouëffic, MD, PhD Department of Vascular Surgery University Hospital of Nantes, France «Unresolved problems of SFA stenting» In-stent restenosis
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationEpidemiology and Pathogenesis of Restenosis
2 Epidemiology and Pathogenesis of Restenosis Randolph L. Geary, MD and Alexander W. Clowes, MD CONTENTS SCOPE AND EPIDEMIOLOGY OF RESTENOSIS PATHOGENESIS OF RESTENOSIS DISCUSSION REFERENCES SCOPE AND
More informationTreating In-Stent Restenosis with Brachytherapy: Does it Actually Work?
Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work? Matthew T. Menard, M.D. Brigham and Women s Hospital Pacific Northwest Endovascular Conference June 15, 2018 DISCLOSURE Matthew Menard,
More informationIntroduction to soft tissues
Modelli Costitutivi dei Materiali Corso di Laurea in Ingegneria Biomedica Pavia, 2013 Introduction to soft tissues Ferdinando Auricchio 1 2 3 4 1 Dipartimento di Ingegneria Civile e Architettura, Università
More informationHealing & Repair. Tissue Regeneration
Healing & Repair Dr. Srikumar Chakravarthi Repair & Healing: Are they same? Repair :Regeneration of injured cells by cells of same type, as with regeneration of skin/oral mucosa (requires basement membrane)
More informationManagement of In-stent Restenosis after Lower Extremity Endovascular Procedures
Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationHistopathology: Vascular pathology
Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these
More informationRoles of Flow Mechanics in Vascular Cell Biology in Health and Disease
Roles of Flow Mechanics in Vascular Cell Biology in Health and Disease Shu Chien Dept. of Bioengineering & Medicine UC, San Diego Presented by Ming-Shaung Ju Dept. of Mech. Eng., NCKU, Tainan Background
More informationDifferential effects of platelet-derived growth factor isoforms on large and small vessel endothelial cells and vascular smooth muscle cells
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1992 Differential effects of platelet-derived growth factor isoforms
More informationBTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration
BTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration M Sapoval, C Del Giudice, C Dean Interventional Radiology Dep Hôpital Européen Georges Pompidou APHP, Paris, France IMPORTANT
More informationBlood Vessel Mechanics
Blood Vessel Mechanics Ying Zheng, Ph.D. Department of Bioengineering BIOEN 326 11/01/2013 Blood Vessel Structure A Typical Artery and a Typical Vein Pressure and Blood Flow Wall stress ~ pressure Poiseuille
More informationSites of Atherosclerosis In order of Frequency
Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary
More informationLUTONIX DCB in AV Access: A Single Center Experience
LUTONIX DCB in AV Access: A Single Center Experience Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name:... I have the following potential
More informationAn Agent-Based Model of the Response to Angioplasty and Bare-Metal Stent Deployment in an Atherosclerotic Blood Vessel
An Agent-Based Model of the Response to Angioplasty and Bare-Metal Stent Deployment in an Atherosclerotic Blood Vessel Antonia E. Curtin 1, Leming Zhou 1,2 * 1 Department of Bioengineering, University
More informationPathology of Restenosis in Saphenous Bypass Grafts After Long-Term Stent Implantation
Pathology of Restenosis in Saphenous Bypass Grafts After Long-Term Stent Implantation Christophe Depre, MD, PhD,1 Xavier Havaux,1 and William Wijns, MD, PhD2 Key Words: Coronary stenting; Restenosis; Saphenous
More informationO ver recent decades, percutaneous interventions
133 REVIEW Drug eluting stents: are human and animal studies comparable? R Virmani, F D Kolodgie, A Farb, A Lafont... Animal models of stenting probably predict human responses as the stages of healing
More informationRestenosis after angioplasty and stenting occurs secondary
Extracellular Matrix Changes in Stented Human Coronary Arteries Andrew Farb, MD; Frank D. Kolodgie, PhD; Jin-Yong Hwang, MD, PhD; Allen P. Burke, MD; Kirubel Tefera, BSc; Deena K. Weber, MS; Thomas N.
More informationCell Proliferation After Balloon Injury of Iliac Arteries in the Cholesterol-Fed New Zealand White Rabbit
727 Cell Proliferation After Balloon Injury of Iliac Arteries in the Cholesterol-Fed New Zealand White Rabbit Michael L. Stadius, Allen M. Gown, Robert Kernoff, Cynthia L. Collins Abstract Acute mechanical
More informationVascular smooth muscle cell phenotypes in primary pulmonary hypertension
Eur Respir J 2001; 17: 316 320 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 CASE STUDY Vascular smooth muscle cell phenotypes in primary
More informationMisrepair mechanism in the development of atherosclerotic plaques
Misrepair mechanism in the development of atherosclerotic plaques Jicun Wang-Michelitsch 1 *, Thomas M Michelitsch 2 1 Department of Medicine, Addenbrooke's Hospital, University of Cambridge, UK (Work
More informationAngiographic long-term results after implantation of the paclitaxel-eluting coronary stent coroflex please : Data under real-world conditions
244 U. Gerk, B. Leithäuser, U. Schäfer, F. Jung, J.-W. Park Applied Cardiopulmonary Pathophysiology 14: 244-249, 2010 Angiographic long-term results after implantation of the paclitaxel-eluting coronary
More informationIn vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG)
In vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG) 1 Dr Saeb Aliwaini 13/11/2015 Migration in vivo Primary tumors are responsible for only about 10%
More informationEvolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands
Evolution In Interventional Cardiology Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands 25 November 2010 Coronary Atherosclerosis Timeline in interventional cardiology Indications for
More informationHealing and Repair. Dr. Nabila Hamdi MD, PhD
Healing and Repair Dr. Nabila Hamdi MD, PhD 1 ILOs Know the classification of human cells according to their ability for proliferation. Understand the mechanism of cellular regeneration. Identify the types
More informationPathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005
Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque
More informationCorMatrix ECM Bioscaffold
CorMatrix ECM Bioscaffold REMODEL. REGROW. RESTORE. CorMatrix ECM Bioscaffold provides a natural bioscaffold matrix that enables the body s own cells to repair and remodel damaged cardio-vascular tissue.
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationBoston Scientific Corporation Drug-Eluting Stent Program
Boston Scientific Corporation Drug-Eluting Stent Program Copyright 2002 by Scimed Life Systems, Inc. All rights reserved. Program Overview λ λ λ λ λ World Wide Status Restenosis Paclitaxel Polymers Dose
More informationThe Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
More informationTHROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan
THROMBOSIS Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan NORMAL BLOOD VESSEL HISTOLOGY THROMBOSIS Pathogenesis (called Virchow's triad): 1. Endothelial*
More informationFMD 101. Esther S.H. Kim, MD, MPH, FACC, FSVM FMDSA Annual Meeting 18 May 2013
FMD 101 Esther S.H. Kim, MD, MPH, FACC, FSVM FMDSA Annual Meeting 18 May 2013 Back to basics Blood Bodily fluid that transports necessary substances (oxygen, nutrients, antibodies, hormones, etc) and waste
More informationThe effect of oestrogen on intimal hyperplasia in cultured human ovarian veins
Human Reproduction vol.13 no.6 pp.1449 1454, 1998 The effect of oestrogen on intimal hyperplasia in cultured human ovarian veins A.Akkad and F.Al-Azzawi 1 Gynaecology Research Group, Department of Obstetrics
More informationSummit TCT Asia Pacific
Summit TCT Asia Pacific Future Horizons in Coronary Stenting Jacques Koolen Md PhD FSCAI Catharina Hospital Eindhoven Netherlands Where are we? Where do we want to go? TODAY - the Drug Eluting Stent DES
More informationAbdominal Exam: The examination of the abdomen used by physicians to detect an abdominal aortic aneurysm.
Glossary of Terms Abdominal Exam: The examination of the abdomen used by physicians to detect an abdominal aortic aneurysm. Angiogram: A diagnostic test requiring the insertion of a catheter into an artery
More informationEARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES
EARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES JAMES M. ANDERSON, MD, PhD DISTINGUISHED UNIVERSITY PROFESSOR DEPARTMENTS OF PATHOLOGY, MACROMOLECULAR SCIENCE, AND BIOMEDICAL ENGINEERING CASE WESTERN
More informationDrug delivery to the vessel wall: Coated balloons and the role of the excipient
Drug delivery to the vessel wall: Coated balloons and the role of the excipient Nathan Lockwood BioInterface 2015 2015 SurModics, Inc. 1 Evolution of Devices & Therapy: POBA to DCB Balloon angioplasty
More informationInnate Immunity in Atherosclerosis
Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015 ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated
More informationand Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine
PPAR- Agonist and In-Stent Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine Peroxisome Proliferator- activated Receptors (PPAR) Lipid-activated transcription factors : => regulating
More informationCatheter Interventions for Kawasaki Disease: Current Concepts and Future Directions
REVIEW DOI 10.4070/kcj.2011.41.2.53 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright 2011 The Korean Society of Cardiology Open Access Catheter Interventions for Kawasaki Disease: Current Concepts
More informationATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall.
ATHEROSCLEROSIS Atherosclerosis Atherosclerosis is a disease process affecting the intima of the aorta and large and medium arteries, taking the form of focal thickening or plaques of fibrous tissue and
More informationPathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL
Pathology of percutaneous interventions (PCI) in coronary arteries Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Percutaneous Coronary Intervention (PCI) Definition: transcatheter opening of
More information1 Functions of endothelial cells include all the following EXCEPT. 2 Response to vascular injury is characterised by
airns ase Hospital mergency epartment Part 1 FM MQs 1 Functions of endothelial cells include all the following XPT Formation of von-willebrand factor Formation of collagen and proteoglycans Formation of
More informationPolyphenol-eluting stent reduces restenosis and promotes vascular healing in a rat model of arterial angioplasty and stenting
Polyphenol-eluting stent reduces restenosis and promotes vascular healing in a rat model of arterial angioplasty and stenting Jim Kleinedler LSU Health Sciences Center Shreveport Department of Pharmacology,
More informationEndovascular beta-irradiation with a liquid 188 Re-filled balloon to reduce restenosis after coronary angioplasty.
Endovascular beta-irradiation with a liquid 188 Re-filled balloon to reduce restenosis after coronary angioplasty. Peix A., Llerena L., Ponce F., López A., López L., Guerrero I., Cabrera L.O., Maltas A.M.,
More informationUNDERSTANDING ATHEROSCLEROSIS
UNDERSTANDING ATHEROSCLEROSIS UNDERSTANDING ATHEROSCLEROSIS ARTERIES Arteries are blood vessels that carry oxygenated blood to all the organs of the body. Arteries are made up of three important layers:
More informationOutcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting
Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting Xue F Y, Bettmann M A, Langdon D R, Wivell W A Record Status
More informationNonsurgical Management of Postoperative Pulmonary Vein Stenosis
Nonsurgical Management of Postoperative Pulmonary Vein Stenosis 부산의대소아청소년과학교실부산대학교어린이병원심장센터 이형두 Postop pulmonary vein stenosis TAPVR or PAPVR repair Primary pulmonary vein stenosis Lung transplantation
More informationDistribution of type IV collagen, laminin, nidogen and fibronectin in the haemodynamically stressed vascular wall
Histol Histopath (1 990) 5: 161-1 67 Histology and Histopathology Distribution of type IV collagen, laminin, nidogen and fibronectin in the haemodynamically stressed vascular wall Reinhold Kittelberger,
More informationHistopathology: healing
Histopathology: healing These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual information that
More informationVulnerable Plaque. Atherothrombosis
Vulnerable Plaque Nuove acquisizioni sull'aterosclerosi: placca vulnerabile Marina Camera Dip. Scienze Farmacologiche, Facoltà di Farmacia, Università degli Studi di Milano & Laboratorio di Biologia Cellulare
More informationFinal Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)
Final results of the feasibility study for the drug-coated Chocolate Touch PTA balloon of of femoropopliteal Femoropopliteal lesions lesions: (The ENDURE Trial) Final Results of the Feasibility Study for
More informationMorphological changes after percutaneous transluminal coronary angioplasty of unstable plaques
European Heart Journal (1996) 17, 1554-1559 orphological changes after percutaneous transluminal coronary angioplasty of unstable plaques Insights from serial angioscopic follow-up C. Bauters, J.-. Lablanche,
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationConstrictive remodeling is a major contributor to restenosis
Eplerenone Suppresses Constrictive Remodeling and Collagen Accumulation After Angioplasty in Porcine Coronary Arteries Michael R. Ward, MBBS, PhD; Peter Kanellakis, BSc; Debra Ramsey; John Funder, MD,
More informationReport For Center Created Gender D.O.B Page 1 Sean Breen HeartSmart IMT plus 3/29/2012 Male 11/26/1973 B C D E
Report For Center Created Gender D.O.B Page 1 Carotid Assessment A B C D E Good Satisfactory Concern Serious Highest Risk Intima-Media Thickness Additional Findings Plaque Character Percent Stenosis Comments:
More informationThoughtful vs. Dogmatic
Debate on Balloon Assisted Maturation The Biology is Wrong: BAM Won t Work BAM Dr. Rapp Debate BIVF Dr. Lawson Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical
More informationAtherosclerosis. Atherosclerosis happens when the blood vessels
Atherosclerosis Atherosclerosis happens when the blood vessels that carry oxygen and nutrients from your heart to the rest of your body (arteries) become thick and stiff sometimes restricting blood flow
More information/96/$5.00-F 0 24/'1/73551
Fogarty and percutaneous transluminal coronary angioplasty balloon injury induce comparable damage to the arterial wall but lead to different healing responses Frits N. G. Doornekamp, MSc, Cornelius Borst,
More informationProgressive neointimal thickening and restenosis remain
Administration of a Decoy Against the Activator Protein-1 Binding Site Suppresses Neointimal Thickening in Rabbit Balloon-Injured Arteries Masazumi Kume, MD; Kimihiro Komori, MD, PhD; Takuya Matsumoto,
More informationResearch Article Cytological Evaluation of Hyaluronic Acid on Wound Healing Following Extraction
Cronicon OPEN ACCESS DENTAL SCIENCE Research Article Cytological Evaluation of Hyaluronic Acid on Wound Healing Following Extraction Gocmen Gokhan 1 *, Gonul O 1, Oktay NS 2, Pisiriciler R 2 and Goker
More informationElastin variations implicating in vascular smooth muscle cells phenotype in human tortuous arteries
Histol Histopathol (2000) 15: 95-1 00 http://www.ehu.es/histol-histopathol Histology and Histopathology Cellular and Molecular Biology Elastin variations implicating in vascular smooth muscle cells phenotype
More informationIL-24 AND ITS ROLE IN WOUND HEALING
IL-24 AND ITS ROLE IN WOUND HEALING Nancy J. Poindexter, Ryan Williams, Garth Powis, Sunil Chada, and Elizabeth A. Grimm & Introgen Therapeutics, Inc., Houston, TX IL-24/MDA 24/MDA-77 is a Tumor Suppressor
More informationTHE BIOLOGY OF PLATELET-GEL THERAPY
THE BIOLOGY OF PLATELET-GEL THERAPY The synopsis of normal healing includes a well known sequence of coordinated phases. The unique process leading to healing is ontologically partitioned in three sequential
More informationas a Mechanism of Stent Failure
In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I
More informationFibromuscular Dysplasia. Miranda Forrest Baker College
Fibromuscular Dysplasia Miranda Forrest Baker College Overview Case Study Patient Information Exam Images Findings FMD Types Signs and Symptoms Treatment Case Study Patient Information Female 57 years
More informationHEART HEALTH WEEK 2 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease ATHEROSCLEROSIS. Fatty deposits can narrow and harden the artery
WEEK 2 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease ATHEROSCLEROSIS FIGURE 1 Atherosclerosis is an inflammatory process where cholesterol is deposited in the wall of arteries and
More informationDrug Eluting Stents: Update
Drug Eluting Stents: Update B. Berekoven Research Coordinator Department of Vascular Surgery St. Franziskus Hospital Münster Head: Univ.- Prof. Dr. G. Torsello baerbel.berekoven@sfh-muenster.de Disclosure
More informationAfter this presentation and discussion, the participants should be able to:
Tissue Repair Robert F. Diegelmann, Ph.D. OBJECTIVES After this presentation and discussion, the participants should be able to: 1. Define the biochemical responses to tissue injury 2. Describe the mechanisms
More informationAtherothrombosis And Coronary Artery Disease
Atherothrombosis And Coronary Artery Disease 1 / 6 2 / 6 3 / 6 Atherothrombosis And Coronary Artery Disease Risk factors for coronary artery disease (CAD) were not formally established until the initial
More informationCoronary Aneurysms After Stent Placement: A Suggestion of Altered Vessel Wall Healing in the Presence of Anti-inflammatory Agents
1524 JACC Vol. 18,. 6 Coronary Aneurysms After Stent Placement: A Suggestion of Altered Vessel Wall Healing in the Presence of Anti-inflammatory Agents S. TANVEER RAB, MD, FACC,* SPENCER B. KING III, MD,
More informationArterial Diseases & Grafts What Can Go Wrong and How to Fix It
Arterial Diseases & Grafts What Can Go Wrong and How to Fix It Lecture #9 Ref: Harloff, Jan, Are Biomaterials the Limiting Factor in the Progress of Arterial Prosthesis? Termpaper, BE 512, introduction
More informationDiseases of the Aorta
Diseases of the Aorta ASE Review 2018 Susan E Wiegers, MD, FASE, FACC Professor of Medicine My great friend Dr. Roberto Lang Disclosure None related to this presentation 1 Objectives Aneurysm Dissection
More informationELUTING NOVEL BIODEGRADABLE VASCULAR STENTS FOR IMPLANTATION
PREDNISOLONE ACETATE-ELUTING ELUTING NOVEL BIODEGRADABLE VASCULAR STENTS FOR IMPLANTATION Pharm. (M.Sc.) Can Sarisozen Assist. Prof. Dr. Betul Arica, Prof.Dr. Sema Calis, Prof.Dr. A.Atilla Hincal Hacettepe
More informationBrachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts
Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts Disclosure Speaker name: Matthew T. Menard... x I do not have
More informationPRP Usage in Today's Implantology
Volume 1, December 2004 www.implant.co.il PRP Usage in Today's Implantology by Dr. R. Shapira Introduction: Treating patients suffering from hematological disorders or using anticoagulant medications always
More informationVascular Smooth Muscle Growth: Autocrine Growth Mechanisms
PHYSIOLOGICAL REVIEWS Vol. 81, No. 3, July 2001 Printed in U.S.A. Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms BRADFORD C. BERK Center for Cardiovascular Research, University of Rochester,
More informationON CELLULAR SOURCES FOR INTIMAL HYPERPLASIA AFTER VASCULAR INTERVENTIONS
Doctoral Thesis for the degree of Doctor of Philosophy, Faculty of Medicine ON CELLULAR SOURCES FOR INTIMAL HYPERPLASIA AFTER VASCULAR INTERVENTIONS Stefan Mellander The Sahlgrenska Academy at Göteborg
More informationACD. The Journal of Thoracic and Cardiovascular Surgery c Volume 139, Number 3 655
A novel approach to prevent spinal cord ischemia: Inoue stent graft with a side branch of small caliber for the reconstruction of the artery of Adamkiewicz Takeshi Shimamoto, MD, a Akira Marui, MD, PhD,
More informationUniversity of Groningen. Transplant Arteriosclerosis and In-Stent Restenosis Onuta, Geanina
University of Groningen Transplant Arteriosclerosis and In-Stent Restenosis Onuta, Geanina IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationIntravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty
IAGS 1996 Proceedings Intravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty Gary S. Mintz, MD, Jeffrey J. Popma, MD, Augusto D. Pichard, MD,
More information